Abstract Library

#3580 Sex differences in survival of neuroendocrine neoplasia in England 1995–2018

Introduction: Sex differences have been noted at different sites of Neuroendocrine Neoplasia in some registry studies internationally. Analysis of England's National Cancer Registry and Analysis Service (NCRAS) data can help to clarify the significance and importance of this.

Conference:

Presenting Author:

Authors: White B, Chandrakumaran K, Wong K, Rous B, Bouvier C,

Keywords: epidemiology, survival, sex, incidence,

#3544 Incidence, prevalence and survival of neuroendocrine neoplasia 1995–2018

Introduction: Incidence of neuroendocrine neoplasia (NEN) is rising worldwide. England's National Cancer Registry and Analysis Service (NCRAS) records more than 99.5% of tumors. Recent improvements to the registry allow NEN to be analysed with greater accuracy.

Conference:

Presenting Author: White B

Authors: White B, Chandrakumaran K, Wong K, Rous B, Bouvier C,

Keywords: epidemiology, incidence, prevalence, survival,

#3447 Access to diagnosis and treatments for patients with neuroendocrine tumors: A survey by the Brazilian Gastrointestinal Tumors Group

Introduction: While new treatments and diagnostic methods for patients (pts) with neuroendocrine neoplasms (NEN) have been incorporated, the extent of such access to Brazilian pts is unknown.

Conference:

Presenting Author:

Authors: Dias C, Peixoto R, Weschenfelder R, Prolla G, Rego J,

Keywords: neuroendocrine neoplasm, access, somatostatin analogues, public health,

#3046 Incidence of Neuroendocrine Neoplasms Reported in England 2015-2017

Introduction: Previously published UK Cancer Registry data showed incidence of Neuroendocrine Neoplasms rising between 2001 and 2015. This was higher than had been thought (Genus et al). We report more recent data with more accurate coding (ICD-O-3).

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: White B, Bouvier C, Genus T, Rous B, Srirajaskanthan R,

Keywords: Epidemiology, Neuroendocrine Neoplasia, Incidence, Prevalence, population data, histopathology,

#2024 Metachronous Primary Cancers in Neuroendocrine Tumor Patients

Introduction: Historically there has been an association between neuroendocrine tumours (NETs) and second primary cancers (Stronge et al 2014). However, this has not been well characterised.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Genus T

Authors: Genus T, Bouvier C, Wong K, Srirajaskanthan R, Rous B,

Keywords: Neuroendocrine cancer, second primary, metachronous,